Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years

Kulkarni, S, Powles, R, Treleaven, J, Singhal, S, Horton, C, Sirohi, B, Bhagawati, N, Tait, D, Saso, R, Killick, S, Pinkerton, R, Atra, A, Meller, S and Mehta, J (2000) Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years. Bone Marrow Transplantation, 25 4: 365-370. doi:10.1038/sj.bmt.1702148


Author Kulkarni, S
Powles, R
Treleaven, J
Singhal, S
Horton, C
Sirohi, B
Bhagawati, N
Tait, D
Saso, R
Killick, S
Pinkerton, R
Atra, A
Meller, S
Mehta, J
Title Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years
Journal name Bone Marrow Transplantation   Check publisher's open access policy
ISSN 0268-3369
Publication date 2000-02-01
Year available 2000
Sub-type Article (original research)
DOI 10.1038/sj.bmt.1702148
Open Access Status Not yet assessed
Volume 25
Issue 4
Start page 365
End page 370
Total pages 6
Publisher STOCKTON PRESS
Language eng
Keyword allogeneic bone marrow transplantation
second malignant neoplasms
conditioning therapy
Bone-Marrow Transplantation
Acute Myeloid-Leukemia
Total-Body Irradiation
Atomic-Bomb Survivors
Secondary Malignancies
Cancer Risk
Remission
Mortality
Adults
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads - Archived
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 12 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 09 Jul 2016, 03:53:59 EST by System User